Company Filing History:
Years Active: 2004
Title: The Innovations of Thierry Boon-Fallaur
Introduction
Thierry Boon-Fallaur is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly through his work on tumor-associated genes. His innovative approach has led to advancements in the diagnosis and treatment of cancer.
Latest Patents
Boon-Fallaur holds a patent for "Mage-A3 peptides presented by HLA class molecules." This invention describes HLA class II binding peptides encoded by the MAGE-A3 tumor-associated gene. The patent also includes nucleic acids encoding such peptides and antibodies related to them. The peptides are designed to stimulate the activity and proliferation of CD4 T lymphocytes. Additionally, methods and products are provided for diagnosing and treating conditions characterized by the expression of the MAGE-A3 gene. He has 1 patent to his name.
Career Highlights
Boon-Fallaur is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to push the boundaries of cancer research. His work has been instrumental in developing new therapeutic strategies that leverage the immune system to combat cancer.
Collaborations
He has collaborated with notable colleagues such as Erwin Schultz and Pascal Chaux, contributing to a dynamic research environment focused on innovative cancer treatments.
Conclusion
Thierry Boon-Fallaur's contributions to cancer research through his patented innovations highlight the importance of scientific advancements in the fight against cancer. His work continues to inspire future research and development in this critical field.